https://www.forbes.com/sites/samshead/2018/08/20/facebook-ai...
If DeepMind is trained on millions of MRI’s, we might have better preventative medicine.
https://www.forbes.com/sites/samshead/2018/08/20/facebook-ai...
If DeepMind is trained on millions of MRI’s, we might have better preventative medicine.
The FDA will probably set the low bar of validating that the reconstruction algorithm fares well in the face of a few abnormalities and call it a day, instead of the proper (admittedly infeasible) validation of testing against all abnormalities that the reconstruction algorithm will encounter. Facebook will probably happily jump over this low bar, and patients will get hurt.
And besides, let’s say tomorrow they have a method to do it tomorrow: how do they prospectively scam patients? How do they deploy the algorithm in a clinical setting? For any of this as a product to work, it would have to be integrated into a mri controller. Unless I’m eating my words at RSNA this year and deep mind is presenting their work, I’ll remain highly skeptical that this is going anywhere beyond a PR story that’s been sold to the media.
1. If an MRI can be done 10x faster with the same results except in exceptionally rare cases, might that not still be a win? Order of magnitude reduction in time may translate to substantial reduction in cost and increase opportunity for applications. It seems like it is worth considering whether these benefits might be worth compromising the accuracy of the imaging.
2. How accurate are radiologists at diagnosing / detecting these rare abnormalities that validation might miss? If radiologists are actually pretty mediocre at this, might it be OK to make the scan slightly imperfect if the next stage (the human) is already very imperfect?
2. There are thousands of different abnormalities. From what I understand about the FDA validation process for this sort of thing there would be only 10s of abnormalities. There are likely, many, many of them that are quite obvious to radiologists. And once again, this would be a question that should be studied carefully when people's lives are at risk, instead of just assuming that it will be fine then going ahead to "move fast and break things"
The argument that "our system is already bad so we should just merge this new bad component because it doesn't make it worse" is bad in software, and unacceptable in medicine.
If the scanning process has a sensitivity of 99.999%, and the next stage in the signal chain has a sensitivity of 50%, and we consider what happens if the MRI sensitivity drops to 99.9%, that's well in the noise in terms of diagnostic value. Use some of the extra money freed up by doing the MRI 10x faster to pay a radiologist to look at the scan for 10% longer, and perhaps the net accuracy has improved.
What is unacceptable about this kind of holistic reasoning about the system? High performing systems are frequently not composed of perfect components.
Omitting 90% of samples (based on 10x speed claim) leaves an awful lot of room for bizarre errors.
I agree 100% with this, but how can this question be studied of this research to develop these systems doesn't go forward? You earlier characterized the FastMRI research as, in your view, "actually very dangerous." As I see it, the research here is potentially extremely valuable, and the danger comes not from the research, but from somebody deciding to deploy it without considering these questions. Typically the road from research program to wide deployment is quite long, and I disagree that we should discourage the research because of potential flaws in the productization process. (Unless there is ill will on the part of the researchers, which I'm assuming there is not).
But if you are trying to bring this to masses one can start with with something "simple" like bones or some some relatively trivial organ. Not that MRI prices themselves are dropping much - gotta wait for room temperature superconductors.
I view the whole issue stochastically, with the immediate aim being to make (significantly) fewer errors than the current approach, which is having a human decide. I don't claim that I can design an experiment which could selve as an indication whether we are improving upon human judgments, but I think this should be the goal.
Reflecting upon my view, i think it comes from the experience of training ml-algorithms. You are always minimizing errors, but you goal is almost never to make 0 errors, because often your data is noisy and you are probably overfitting. I know the medical enviroments are more sensitive, but I can't really wrap my head around how we could design a learning algorithms that does not make any error and works on all abnormalies. I think it will always missclassify.
Rephrasing my argument: I think the approval should be given if an significant expected improvement over the distribution of real-life abnormalies can be detected and not over the uniform-dsitribution over all abnormalies.
EDIT: detecting out-of-distribution samples is hard and I don't think this is a solution and leads to a false sense of security.
The problem with neural networks is that they can reconstruct something that looks "normal", not necessarily something that is accurate. The more abnormal the scan, the more likely it will get reconstructed as something that looks perfectly fine even when it's not.
What I meant: There's probably a medical reason why you want such a product and if a more readily available MRI saves (really significantly) more lives than the chance that it might miss some abnormalies which could lead to death, then I think we should allow it. That's what I meant with a stochastic view. If we, for example, only have a few scans per hospital available because the chance might exist that we missclassify something and lots of people get worse or delayed treatment because they are not high enough on the priority list to get access to a super-resulution MRI with a fidelity they don't really need (again, i don't know anything, just to illustrate my point), then I think something is wrong.
His argument just sounded dismissive without giving a, to my uninformed point of view, valid reason.
Rather than saying "very dangerous", it would be safe to say that some individuals woudl not be well-served, but ideally, the overall health of the population would increase for a reasonable expenditure.
The key will be to train artificial neural networks to recognise the underlying structure of the images in order to fill in detail omitted from an accelerated scan."
Ah, right, what I want is for an ANN to invent information in a medical image. It's one thing to upscale textures in a game, but I can't see the use for this at all in a medical imaging device.
The point here is making people healthy, not providing some sort of validated theoretically clean design. If the rcts say it works, bring on the deep learning voodoo.
(edit: I, for the record, want to trust in average accuracy.)
Even if it happens more rarely than a doctor missing an anomaly on the scan, it doesn't feel right. A patient had a good chance to be diagnosed and he wasn't.
What's more, in case of normal MRI a patient or a doctor can ask another doctor to have a look, but in case of AI and the fast scan described in the article, the AI's interpretation of data is final, unless you go make another scan, this time in the traditional way.
You're focusing on the person who got falsely detected as healthy, and are ignoring the people who would be correctly detected as unhealthy. That's why the important question is expected outcomes.
I don't really care whether the doctor gets to be morally culpable or not. I'm not sure why I would ever care about something like that as a patient. If I get sick and die, the fact that a person was responsible rather than an algorithm gives me precisely zero comfort.
You don't need high costs to charge a lot.
They were pitching it to a medical group, and they were like that's great for patient care but how does it cut costs to the organization...
Adding more "cameras" to our MRI so we can do parallel imaging is expensive.
From the perspective of a MRI purchaser (say clinic or hospital director), maybe you can squeeze 1 or 2 more cases in a day, but it seems like a marginal improvement overall. I think cardiac is clearly the exception where you bring on board potentially new functionality with quicker acquisition.